Lab

He Jiankui, PhD, a Chinese scientist who sparked controversy in 2018 after claiming to have genetically modified two human embryos, is on a new scientific endeavor: trying to develop a therapy for Duchenne muscular dystrophy, NPR reported June 8.

On Feb. 24, the FDA issued an emergency use authorization for the first over-the-counter rapid test that can detect both COVID-19 and flu. However, it's unclear when the test might be available to consumers as Lucira Health, the test's developer,…

Quest Diagnostics has agreed to acquire some laboratory services assets from New York City-based NewYork-Presbyterian.

A team of engineers and infectious disease researchers at Washington University in St. Louis developed a new rapid point-of-care diagnostic test that is 1,000 times more sensitive than conventional tests.

The FDA cleared for commercial distribution a diagnostic panel that tests for multiple respiratory viral and bacterial infections on Feb. 3.

Grand Junction, Colo.-based Saint Mary’s Hospital is opening a $52.8 million laboratory, ABC affiliate KJCT8 reported Feb. 1.

Kansas City-based University of Kansas Medical Center researchers created an artificial intelligence model that can predict urinary tract infection without a microscopy, WFMZ reported Jan. 23.

BD, a global medtech company, and CerTest Biotec have received emergency use authorization from FDA for their polymerase chain reaction mpox test. 

Labcorp has kicked off operations at an LA-based anatomic pathology and histology lab.

A Dec. 6 OIG report found that 378 labs billed Medicare Part B at questionably high levels for test add-ons.